Immune checkpoint inhibitors were not associated with poor asthma control in patients with pre-existing asthma [0.03%]
免疫检查点抑制剂不会影响伴有哮喘患者的肺功能及哮喘控制程度
Parker Cordial,Sritej Devineni,Jianing Ma et al.
Parker Cordial et al.
Background: Immune checkpoint inhibitors (ICIs) are associated with various pulmonary toxicities. Their impact on pre-existing asthma remains poorly characterized. ...
Lower lung function and respiratory symptoms are associated with reduced accelerometer-measured physical activity in middle-aged adults [0.03%]
肺功能降低和呼吸系统症状会使得中年人的日常身体活动量减少
Anders Blomberg,Daniel Arvidsson,Örjan Ekblom et al.
Anders Blomberg et al.
Background: Physical activity (PA) has well-documented cardio-respiratory protective effects in individuals with lung diseases. Whilst most studies examining the relationship between PA, lung function and respiratory symp...
Association of the C-reactive protein-triglyceride-glucose (CTI) index with asthma prevalence: Evidence from dual national cohorts [0.03%]
C反应蛋白-甘油三酯-血糖指数与哮喘流行率的关系：来自两个国家级队列的证据
Wenxuan Zhang,Liya Li,Shuting Du et al.
Wenxuan Zhang et al.
Background: The association between the C-reactive protein-triglyceride-glucose (CTI) index and prevalent asthma was examined in two national cohorts. Met...
Impact of comorbidities on endobronchial valve treatment response in severe emphysema patients [0.03%]
并存症对重度肺气肿患者支气管内阀治疗反应的影响
Else A M D Ter Haar,Dirk-Jan Slebos,Sonja W S Augustijn et al.
Else A M D Ter Haar et al.
Background and objective: Endobronchial valve (EBV) therapy is an established intervention for patients with advanced emphysema with lung hyperinflation, improving pulmonary function, exercise capacity, and quality of lif...
Anxiety Sensitivity in Heart Failure with Preserved Ejection Fraction: Bias in Dyspnea Ratings and Respiratory Exercise Response [0.03%]
射血分数保留的心力衰竭患者中的焦虑敏感性：呼吸困难评分偏差和呼吸运动反应偏见
Thomas Ritz,Niya Kelley,Bryce N Balmain et al.
Thomas Ritz et al.
Background: Anxiety sensitivity, the fear of anxiety symptoms, is linked to elevated symptom reports in health and illness. Dyspnea on exertion, a dominant complaint in heart failure with preserved ejection fraction (HFpE...
Gaps in Physiotherapy Capacity to Provide Long COVID Rehabilitation Care [0.03%]
物理治疗提供长期新冠肺炎康复护理的能力差距
Débora M Petry Moecke,Evan H Kwong,Jennifer Yao et al.
Débora M Petry Moecke et al.
Rationale: Long COVID is a complex multisystemic condition often associated with persistent cardiorespiratory symptoms. Rehabilitation is key for managing symptoms, but there are questions about the capacity of rehabilita...
Mathematically optimized mechanical power as a potential approach for tailored lung protection [0.03%]
数学优化的机械功率作为量身定制肺保护的一种潜在方法
Diego Ugalde
Diego Ugalde
Background: During mechanical ventilation, obtaining mechanical power might allow us to tailor energy applied to the respiratory system, however its use is not widespread and adjustment can be cumbersome. A mathematical o...
Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease [0.03%]
神经肌肉接头生物标志物CAF22可预测慢性阻塞性肺疾病患者的功能减退
Rizwan Qaisar,Imran Ullah Khan,Asima Karim et al.
Rizwan Qaisar et al.
Purpose: Functional decline is common in chronic obstructive pulmonary disease (COPD) and is not fully explained by pulmonary impairment. Early biological markers capable of identifying patients at risk of accelerated phy...
Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients [0.03%]
急性肺栓塞后长期呼吸和肺血管预后的性别差异：795,338例患者倾向匹配分析
Aabha Divya,Niti Dalal,Sravanthi Nandavaram et al.
Aabha Divya et al.
Background: Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism remain incompletely defined. Obj...
Clinical and biochemical response to elexacaftor/tezacaftor/ivacaftor in a patient with the rare L927P/N1303K CFTR genotype [0.03%]
携带罕见CFTR基因L927P/N1303K复合杂合突变囊性纤维化患者接受elexacaftor/tezacaftor/ivacaftor治疗的临床及生化学应答反应分析报告
Sayed Alwadaei,Emily Chellam,Nicki Allsup et al.
Sayed Alwadaei et al.
Elexacaftor/tezacaftor/ivacaftor (ETI) has transformed the treatment of cystic fibrosis (CF), although evidence in individuals carrying rare CFTR variants remains limited. We report the clinical and biochemical response to ETI in a 25-year-...